Segura J - Search Results

1

Variations in Circulating Active MMP-9 Levels During Renal Replacement Therapy.

Rodríguez-Sánchez E, Navarro-García JA, Aceves-Ripoll J, Abarca-Zabalía J, Susmozas-Sánchez A, Bada-Bosch T, Hernández E, Mérida-Herrero E, Andrés A, Praga M, Fernández-Ruiz M, Aguado JM, Segura J, Ruilope LM, Ruiz-Hurtado G. Rodríguez-Sánchez E, et al. Among authors: segura j. Biomolecules. 2020 Mar 26;10(4):505. doi: 10.3390/biom10040505. Biomolecules. 2020. PMID: 32225016 Free PMC article.

2

Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.

Praga M, Paz Artal E, Hernández E, Segura J, Moreno MA, Morales JM, Rodicio JL. Praga M, et al. Among authors: segura j. Nephrol Dial Transplant. 1997 Dec;12(12):2576-9. doi: 10.1093/ndt/12.12.2576. Nephrol Dial Transplant. 1997. PMID: 9430854 Clinical Trial.

3

Influence of hepatitis C virus infection on FK 506 blood levels in renal transplant patients.

Manzanares C, Moreno M, Castellanos F, Cubas A, Herrero JC, Morales-Ruiz E, Segura J, Andres A, Morales JM. Manzanares C, et al. Among authors: segura j. Transplant Proc. 1998 Jun;30(4):1264-5. doi: 10.1016/s0041-1345(98)00235-8. Transplant Proc. 1998. PMID: 9636513 Clinical Trial. No abstract available.

4

Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study.

Campistol JM, Mazuecos A, Segura J, Osuna A, Herrero JC, Andres A, Oppenheimer F, Gomez de la Camara A, Martinez MA, Morales JM. Campistol JM, et al. Among authors: segura j. Transplant Proc. 1999 Sep;31(6):2267-9. doi: 10.1016/s0041-1345(99)00332-2. Transplant Proc. 1999. PMID: 10500571 Clinical Trial. No abstract available.

5

Comparative study of home and office blood pressure in hypertensive patients treated with enalapril/HCTZ 20/6 mg: the ESPADA study.

Campo C, Fernández G, González-Esteban J, Segura J, Ruilope LM; ESPADA Study Group. Campo C, et al. Among authors: segura j. Blood Press. 2000;9(6):355-62. doi: 10.1080/080370500300000941. Blood Press. 2000. PMID: 11212065

6

A prospective comparison of four antihypertensive agents in daily clinical practice.

Campo C, Segura J, Fernández ML, Guerrero L, Christiansen H, Ruilope LM. Campo C, et al. Among authors: segura j. J Clin Hypertens (Greenwich). 2001 May-Jun;3(3):139-44. doi: 10.1111/j.1524-6175.2001.00448.x. J Clin Hypertens (Greenwich). 2001. PMID: 11430394 Free PMC article. Clinical Trial.

7

The calcium channel blocker controversy in patients with diabetic nephropathy: Is there an issue?

Ruilope LM, Campo C, Segura J. Ruilope LM, et al. Among authors: segura j. Curr Hypertens Rep. 2001 Oct;3(5):419-21. doi: 10.1007/s11906-001-0060-4. Curr Hypertens Rep. 2001. PMID: 11551377 Review.

8

ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis.

Segura J, Campo C, Rodicio JL, Ruilope LM. Segura J, et al. Hypertension. 2001 Sep;38(3 Pt 2):645-9. doi: 10.1161/hy09t1.096184. Hypertension. 2001. PMID: 11566948

9

What is the optimal blood pressure target in renal patients?

Ruilope LM, Campo C, Segura J, Rodicio JL. Ruilope LM, et al. Among authors: segura j. Adv Nephrol Necker Hosp. 2001;31:43-53. Adv Nephrol Necker Hosp. 2001. PMID: 11692470 Review.

10

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M. Torres A, et al. Among authors: segura j. Kidney Int. 2002 Jan;61(1):219-27. doi: 10.1046/j.1523-1755.2002.00124.x. Kidney Int. 2002. PMID: 11786104 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,249 results

Search Page